| LDR | | 05326cam a2200745 i 4500 |
| 001 | | 000000480324 |
| 005 | | 20230210094530 |
| 006 | | m d |
| 007 | | cr cn||||||||| |
| 008 | | 220302s2022 dcua ob 000 0 eng |
| 010 | |
▼a 2021949602 |
| 016 | 7 |
▼a 9918366141406676
▼2 DNLM |
| 019 | |
▼a 1295212304
▼a 1295214934
▼a 1295243851 |
| 020 | |
▼a 0309269474 |
| 020 | |
▼a 9780309269476
▼q (electronic bk.) |
| 020 | |
▼z 9780309269452 |
| 020 | |
▼z 0309269458 |
| 035 | |
▼a 3165662
▼b (N$T) |
| 035 | |
▼a (OCoLC)1296428759
▼z (OCoLC)1295212304
▼z (OCoLC)1295214934
▼z (OCoLC)1295243851 |
| 040 | |
▼a NLM
▼b eng
▼e rda
▼c NLM
▼d YDX
▼d EBLCP
▼d OCLCO
▼d OCLCF
▼d N$T
▼d 247004 |
| 042 | |
▼a pcc |
| 050 | 4 |
▼a QR177 |
| 060 | 00 |
▼a QW 45 |
| 082 | 04 |
▼a 616.9041
▼2 23/eng/20230106 |
| 245 | 00 |
▼a Combating antimicrobial resistance and protecting the miracle of modern medicine/
▼c Guy H. Palmer, Gillian J. Buckley, editors ; Committee on the Long-Term Health and Economic Effects of Antimicrobial Resistance in the United States, Board on Population Health and Public Health Practice, Health and Medicine Division, the National Academies of Sciences, Engineering, Medicine. |
| 264 | 1 |
▼a Washington, DC :
▼b National Academies Press,
▼c [2022] |
| 300 | |
▼a 1 online resource (1 PDF file (xxviii, 365 pages)):
▼b illustrations. |
| 336 | |
▼a text
▼b txt
▼2 rdacontent |
| 337 | |
▼a computer
▼b c
▼2 rdamedia |
| 338 | |
▼a online resource
▼b cr
▼2 rdacarrier |
| 490 | 1 |
▼a Consensus study report of the National Academies of Sciences, Engineering, Medicine |
| 504 | |
▼a Includes bibliographical references. |
| 505 | 0 |
▼a Intro -- FrontMatter -- Reviewers -- Preface -- Acknowledgments -- Contents -- Boxes, Figures, and Tables -- Acronyms and Abbreviations -- Summary -- 1 Introduction -- 2 The Scope of the Problem -- 3 The Health and Economic Burden of Resistance -- 4 Strengthening Surveillance -- 5 Stewardship and Infection Prevention -- 6 Bringing New Products to Market and Ensuring Their Reach -- 7 The National Action Plan for Combating Antibiotic-Resistant Bacteria -- 8 A Role for the United States in Coordinated Global Action -- Appendix A: Committee Member Biographies |
| 505 | 8 |
▼a Appendix B: Disclosure of Unavoidable Conflict of Interest -- Appendix C: Open Session Agendas |
| 520 | 3 |
▼a Antimicrobial resistance is a health problem that threatens to undermine almost a century of medical progress. Moreover, it is a global problem that requires action both in the United States and internationally. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine discusses ways to improve detection of resistant infections in the United States and abroad, including monitoring environmental reservoirs of resistance. This report sets out a strategy for improving stewardship and preventing infections in humans and animals. The report also discusses the strength of the pipeline for new antimicrobial medicines and steps that could be taken to bring a range of preventive and therapeutic products for humans and animals to the market. |
| 536 | |
▼a This project has been funded in whole or in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN263201800029I, Task Order No. 75N98020F00003. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project. |
| 588 | |
▼a Description based on online resource; title from PDF title page (viewed April 20, 2022). |
| 590 | |
▼a WorldCat record variable field(s) change: 050, 082 |
| 650 | 0 |
▼a Drug resistance in microorganisms. |
| 650 | 0 |
▼a Anti-infective agents. |
| 650 | 0 |
▼a Environmental monitoring. |
| 650 | 12 |
▼a Drug Resistance, Microbial |
| 650 | 12 |
▼a Drug Resistance, Bacterial |
| 650 | 22 |
▼a Anti-Infective Agents |
| 650 | 22 |
▼a Anti-Bacterial Agents |
| 650 | 22 |
▼a Antimicrobial Stewardship |
| 650 | 22 |
▼a Environmental Monitoring |
| 650 | 6 |
▼a Micro-organismes
▼x Re?sistance aux me?dicaments. |
| 650 | 6 |
▼a Bacte?ries pathoge?nes
▼x Re?sistance aux me?dicaments. |
| 650 | 6 |
▼a Antiinfectieux. |
| 650 | 6 |
▼a Environnement
▼x Surveillance. |
| 650 | 7 |
▼a Anti-infective agents.
▼2 fast
▼0 (OCoLC)fst00810345 |
| 650 | 7 |
▼a Drug resistance in microorganisms.
▼2 fast
▼0 (OCoLC)fst00898704 |
| 650 | 7 |
▼a Environmental monitoring.
▼2 fast
▼0 (OCoLC)fst00913214 |
| 651 | 2 |
▼a United States |
| 700 | 1 |
▼a Buckley, Gillian J.,
▼e editor, |
| 700 | 1 |
▼a Palmer, Guy
▼q (Guy Hughes),
▼d 1955-
▼e editor, |
| 710 | 2 |
▼a National Academies of Sciences, Engineering, and Medicine (U.S.).
▼b Committee on the Long-Term Health and Economic Effects of Antimicrobial Resistance in the United States,
▼e issuing body. |
| 776 | 08 |
▼i Print version:
▼a National Academies of Sciences, Engineering, and Medicine
▼t Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine
▼d Washington, D.C. : National Academies Press,c2022
▼z 9780309269452 |
| 830 | 0 |
▼a Consensus study report. |
| 856 | 40 |
▼3 EBSCOhost
▼u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=3165662 |
| 938 | |
▼a EBSCOhost
▼b EBSC
▼n 3165662 |
| 990 | |
▼a ***1818828 |
| 991 | |
▼a E-BOOK |
| 994 | |
▼a 92
▼b N$T |